Navigation Links
Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
Date:5/4/2011

NEW YORK, May 4, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease ("Keryx" or the "Company"), today announced the pricing of an underwritten registered offering of 7,021,277 shares of its common stock at a price of $4.70 per share.

The aggregate gross proceeds, before commissions and expenses, of the offering will be approximately $33.0 million.  All of the shares are being sold by the Company. The offering is expected to close on May 9, 2011, subject to customary closing conditions.

Stifel Nicolaus Weisel is acting as the sole book-running manager in this offering with Oppenheimer & Co. Inc., Roth Capital Partners, Rodman & Renshaw, LLC, Brean Murray, Carret & Co. and Ladenburg Thalmann & Co. Inc. acting as co-managers, and JMP Securities LLC acting as financial advisor to the Company.  

The shares will be issued pursuant to a shelf registration statement on Form S-3 previously filed with and declared effective by the Securities and Exchange Commission. The Company also will file with the Securities and Exchange Commission a prospectus supplement with respect to the offering.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the prospectus supplement and accompanying prospectus may be obtained, when available, by mail from: Stifel, Nicolaus & Company, Incorporated, Equity Syndicate Department, One Montgomer
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
2. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
3. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
5. Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundations 2011 Spring Clinical Meetings
6. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
7. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
8. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
9. Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference
10. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
11. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 16, 2015 Mindray Medical International Limited (NYSE: ... marketer of medical devices worldwide, announced today that ... Commission an Annual Report on Form 20-F that included ... 2014. An electronic version of Mindray,s Annual Report ... relations website at  http://ir.mindray.com  or  http://www.sec.gov . ...
(Date:4/16/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... on Tuesday, April 21, 2015, after the close of ... by a conference call with the investment community at ... will be Robert A. Bradway , chairman and ... management team. Live audio of the conference ...
(Date:4/16/2015)...  Rosewind Corporation (OTCMKTS: RSWN) announced today that ... newly formed specialty healthcare company focused on redox-modulated ... disorders. The merged company, which is expected to ... and incorporates the pipeline assets of both Vyrix ... to build a late-stage and commercial pipeline of ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
... Menicon Co., Ltd. (Menicon) announced the appointment of Chew Hwee ... office in Nagoya, Japan. Chew, to be based in Nagoya, ... as well as external relations to support the company,s globalization. ... Economic Development Board (EDB). During his nine-year tenure with the ...
... Aug. 31 Zimmer Holdings, Inc. (NYSE: ZMH ... that it will be participating in the Morgan Stanley Global ... 13, 2010 at 8:35 a.m. Eastern Time. A ... Investor Relations website at http://investor.zimmer.com .  The webcast will ...
Cached Medicine Technology:Former Singapore EDB Officer, Chew Hwee Yong, Joins Menicon as Chief of Special Projects as Menicon Accelerates its Globalization 2Zimmer Holdings to Present at Morgan Stanley Global Healthcare Unplugged Conference 2Zimmer Holdings to Present at Morgan Stanley Global Healthcare Unplugged Conference 3
(Date:4/17/2015)... Texas (PRWEB) April 17, 2015 From the ... years ago, the Texas non-profit organization has empowered young people ... its effort to bring fresh water and the Gospel ... with Liberty University. Between March 17 and 27, students, faculty ... provide 7,000 Liberians with fresh water and the Good News ...
(Date:4/17/2015)... Rapids, MI (PRWEB) April 17, 2015 Enthusiasts ... CRUSH Grand Rapids, Saturday, April 25, 2015. The event will ... Reserve Wine & Food (201 Monroe Ave NW, Grand Rapids, ... from around the West Michigan area. Patrons are encouraged to ... of elegance and fun. , This year’s event will feature ...
(Date:4/17/2015)... 2015 Testosterone treatment lawsuits ( ... prescription medications increases the likelihood that a man ... life-threatening cardiovascular event continue to mount in a ... District of Illinois. According to an updated Statistics ... Multidistrict Litigation (JPML) on April 15th, 1,382 cases ...
(Date:4/17/2015)... Francisco, CA (PRWEB) April 17, 2015 The American ... House event and Free Application Day on April 29. The event ... ACTCM Pioneer Square, located at 555 DeHaro St. in San Francisco, ... 11 a.m. – Check in at the DeHaro campus (room F), ... – Tour of campus, Noon – Light lunch with current students, ...
(Date:4/17/2015)... 17, 2015 With Dr. Taj Haynes ... has spent the last four years providing residents of ... ranging from general cleanings to dental implants and Invisalign ... at their new office in North Charlotte. , The ... their Concord office, including denture fittings, cosmetic procedures, and ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... if there is no sound (silence). The brain is activated ... ,Pierre Fonlupt and Julien Voisin conducted the research ... activity of 11patients who were at rest with the help ... were actually listening to silence and also listen for the ...
... pain and very pale skin can all be early warning ... ,Thousand’s of children's lives will be saved the ... parents, which could speed diagnosis and treatment. ,Until ... child having a headache, stiff neck, sensitivity to light and ...
... team from McMaster University in their clinical trial reported ... drugs such as amiodarone combined with beta blockers such ... in ventricular arrhythmia patients undergoing Implantable Cardioverter defibrillator (ICD). ... to treat fatal cases of ventricular arrhythmias, but these ...
... a time when there is lot of relaxation in weight reduction ... to get this going is to listen to one’s inner voice ... ,Usually the little inner voice starts piping up as you lie ... "Take a handful of those potato chips," it urges., ...
... of H5N1 bird flu strain in Turkey had led to ... summer to avoid spread of bird flu virus into Britain. ... tourists are booking holidays in Turkish resorts.// The Association of ... Turkey is as usual and people seem to be not ...
... study conducted in Japan it has been shown that tomato ... is a known cause of the lung-destroying disease. // ... in tomatoes. ,This study appears to be the ... ,As a cautionary word by the researchers, 'We can't simply ...
Cached Medicine News:Health News:New warning signs for child meningitis 2Health News:Being Active In Winter Despite That Inner Urge 2
... Portex® Blue Line® uncuffed endotracheal ... or Murphy styles, in standard ... Line® adult and pediatric uncuffed ... implant-tested polyvinyl chloride with a ...
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
Ruschelit® PVC. Murphy eye-nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Ruschelit® PVC. Magill tip - nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Medicine Products: